{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05846516",
            "orgStudyIdInfo": {
                "id": "KISIMA-02"
            },
            "organization": {
                "fullName": "Amal Therapeutics",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate ATP150/ATP152, VSV-GP154 and Ezabenlimab in Patients With KRAS G12D/G12V Mutated PDAC (KISIMA-02)",
            "officialTitle": "A Phase 1b Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of ATP150/ATP152, VSV-GP154 and Ezabenlimab (BI 754091) in Patients With KRAS G12D/G12V Mutated Pancreatic Ductal Adenocarcinoma (KISIMA-02)",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-to-evaluate-vsv-and-ezabenlimab-in-patients-with-kras-mutated-pdac-kisima"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-03-13",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-04-18",
            "studyFirstSubmitQcDate": "2023-05-04",
            "studyFirstPostDateStruct": {
                "date": "2023-05-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-04",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-08",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Amal Therapeutics",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Boehringer Ingelheim",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this clinical trial is to test an experimental treatment (immunotherapy) in pancreatic cancer patients. The main research objectives are:\n\n* to evaluate if the KISIMA-02 treatment is safe and well-tolerated (first part)\n* to evaluate if the KISIMA-02 treatment has an impact on the time to observe a possible reappearance of the tumor (second part)\n\nParticipants will receive:\n\ni) a therapeutic protein vaccine ATP150 or ATP 152 ii) a viral vector VSV-GP154 iii) an immune checkpoint inhibitor Ezabenlimab In the second part of the study, researchers will compare treatment group versus observational group.",
            "detailedDescription": "This is an open-label, phase 1b study to evaluate the safety, tolerability, immunogenicity and preliminary efficacy of a heterologous prime-boost vaccine (protein and viral vector) regimen without/with the PD-1 inhibitor Ezabenlimab.\n\nCOMPLETED - Part A (metastatic and locally advanced PDAC patients) Cohort A: ATP150/ATP152 and VSV-GP154 treatment\n\nONGOING - Part B (locally advanced and resected PDAC patients) Cohort B: ATP150/ATP152, Ezabenlimab and VSV-GP154 treatment Cohort B1, B2, B3: dose escalation\n\nNOT STARTED YET - Part C (resected PDAC patients) Cohort C: ATP150/ATP152, Ezabenlimab and VSV-GP154 treatment (treatment versus observational arm)"
        },
        "conditionsModule": {
            "conditions": [
                "Pancreatic Ductal Adenocarcinoma"
            ],
            "keywords": [
                "KISIMA-02",
                "PDAC",
                "ATP150",
                "ATP152",
                "Ezabenlimab",
                "VSV-GP154",
                "Adjuvant setting",
                "Resected pancreatic ductal adenocarcinoma",
                "Metastatic pancreatic ductal adenocarcinoma",
                "Locally advanced pancreatic ductal adenocarcinoma",
                "Resected PDAC",
                "Metastatic PDAC",
                "LAPC"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "For Part C: parallel and randomized",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 85,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort A",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: VSV-GP154",
                        "Drug: ATP150",
                        "Drug: ATP152"
                    ]
                },
                {
                    "label": "Cohort B",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: VSV-GP154",
                        "Drug: ATP150",
                        "Drug: ATP152",
                        "Drug: Ezabenlimab"
                    ]
                },
                {
                    "label": "Cohort C Treatment",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: VSV-GP154",
                        "Drug: ATP150",
                        "Drug: ATP152",
                        "Drug: Ezabenlimab"
                    ]
                },
                {
                    "label": "Cohort C Observational",
                    "type": "NO_INTERVENTION"
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "VSV-GP154",
                    "description": "Injection",
                    "armGroupLabels": [
                        "Cohort A",
                        "Cohort B",
                        "Cohort C Treatment"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "ATP150",
                    "description": "Injection",
                    "armGroupLabels": [
                        "Cohort A",
                        "Cohort B",
                        "Cohort C Treatment"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "ATP152",
                    "description": "Injection",
                    "armGroupLabels": [
                        "Cohort A",
                        "Cohort B",
                        "Cohort C Treatment"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Ezabenlimab",
                    "description": "Infusion",
                    "armGroupLabels": [
                        "Cohort B",
                        "Cohort C Treatment"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Occurrence of dose-limiting toxicity (DLT)",
                    "description": "Part A and B",
                    "timeFrame": "Over at least 35 days"
                },
                {
                    "measure": "Disease-free survival (DFS), defined as the time from randomization until confirmed relapse or death from any cause, whichever occurs earlier.",
                    "description": "Part C",
                    "timeFrame": "Throughout the study, on average 2.4 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Proportion of patients achieving ctDNA clearance",
                    "description": "Part C",
                    "timeFrame": "Up to 12 months"
                },
                {
                    "measure": "Proportion of patients experiencing ctDNA non-progression",
                    "description": "Part C",
                    "timeFrame": "up to 12 months"
                },
                {
                    "measure": "Occurrence of dose-limiting toxicity (DLT)",
                    "description": "Part C",
                    "timeFrame": "Throughout the study, up to 7.5 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key inclusion criteria\n\n* Histologically or cytologically confirmed pancreatic ductal adenocarcinoma (PDAC) with KRAS G12D or KRAS G12V mutation.\n* ECOG performance status of 0 or 1.\n* Patients with advanced or metastatic disease who completed at least 16 weeks of standard systemic chem-/chemoradiotherapy and achieved a partial response or stable disease.\n* Patients who underwent confirmed R0 or R1 resection and completed at least 3 months of combined peri-adjuvant multiagent chemotherapy.\n* No evidence of disease progression or recurrence.\n* Start of study treatment within 12 weeks from the last curative treatment (resected PDAC).\n* Life expectancy at least 12 months (resected PDAC), or at least 6 months (advanced/metastatic PDAC).\n* Archival tumor tissue availability for central KRAS analysis.\n\nKey exclusion criteria\n\n* Not yet recovered from surgery (resected PDAC).\n* Gastro-intestinal bowel obstruction.\n* Other malignancy within the last 3 years.\n* Prior chemotherapy or targeted small molecule therapy within 14 (locally advanced/metastatic PDAC) or 28 (resected PDAC) days from initiation of study treatment.\n* Prior radiotherapy within 14 (advanced/metastatic PDAC) or 28 (resected PDAC) days from initiation of study treatment.\n* Prior use of immunotherapeutic agents, including but not limited to checkpoint inhibitors or VSV-based agents.\n* Diagnosis of immunodeficiency.\n* Chronic systemic treatment with steroids or other immunosuppressive medications.\n* Active autoimmune disease requiring systemic treatment within the last 2 years.\n* Use of Tamoxifen within 1 month prior to start of study treatment",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "AMAL Therapeutics",
                    "role": "CONTACT",
                    "phone": "+41 (0) 22 594 39 52",
                    "email": "RESContact.GVA@boehringer-ingelheim.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Paul Oberstein, MD",
                    "affiliation": "NYU Langone Health",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Shubham Pant, MD",
                    "affiliation": "M.D. Anderson Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "USC/Norris Comprehensive Center",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90033",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Victoria Soto",
                            "role": "CONTACT",
                            "email": "soto_v@med.usc.edu"
                        },
                        {
                            "name": "Heinz-Josef Lenz, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "University of California Los Angeles (UCLA)",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lisa-Maria Yonemoto",
                            "role": "CONTACT",
                            "email": "LYonemoto@mednet.ucla.edu"
                        },
                        {
                            "name": "Zev Aryeh Wainberg, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "University of Colorado Hospital",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Russen McKenna",
                            "role": "CONTACT",
                            "email": "Mckenna.russen@cuanschutz.edu"
                        },
                        {
                            "name": "Sunnie S. Kim, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "University of Florida",
                    "status": "RECRUITING",
                    "city": "Gainesville",
                    "state": "Florida",
                    "zip": "32610-0278",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Britanny Lansford",
                            "role": "CONTACT",
                            "email": "bpolo6962@ufl.edu"
                        },
                        {
                            "name": "Thomas J. George, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.65163,
                        "lon": -82.32483
                    }
                },
                {
                    "facility": "Orlando Health",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32806",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Melinda Janice Porter",
                            "role": "CONTACT",
                            "phone": "(321)841-7246",
                            "email": "Janice.Porter@orlandohealth.com"
                        },
                        {
                            "name": "Omar Kayaleh, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "Karmanos Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Paige Buzenski",
                            "role": "CONTACT",
                            "email": "buzenskp@karmanos.org"
                        },
                        {
                            "name": "Anthony Shields, MD,PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "NYU Langone Health",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10016",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Pharr",
                            "role": "CONTACT",
                            "email": "CT.gov@nyulangone.org"
                        },
                        {
                            "name": "Paul Oberstein, MD, MS",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "University Hospitals Cleveland Medical Center",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44106",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Layla Labbaf",
                            "role": "CONTACT",
                            "email": "layla.labbaf@uhhospitals.org"
                        },
                        {
                            "name": "Amit Mahipal, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "The University of Texas MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Leena Abraham",
                            "role": "CONTACT",
                            "email": "labraha@mdanderson.org"
                        },
                        {
                            "name": "Shubham Pant, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "START - South Texas Accelerated Research Therapeutics",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Elizabeth Gomez",
                            "role": "CONTACT",
                            "email": "Elizabeth.Gomez@startsa.com"
                        },
                        {
                            "name": "Drew Rasco, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Virginia Cancer Specialists",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Carrie Friedman, RN",
                            "role": "CONTACT",
                            "email": "Carrie.Friedman@usoncology.com"
                        },
                        {
                            "name": "Alexander Spira, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Virginia Mason Medical Center",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98101",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mannat Sukhija",
                            "role": "CONTACT",
                            "email": "mannat.sukhija@virginiamason.org"
                        },
                        {
                            "name": "Vincent Joseph Picozzi, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "University Hospital of Lausanne (CHUV)",
                    "status": "RECRUITING",
                    "city": "Lausanne",
                    "state": "Default",
                    "zip": "1011",
                    "country": "Switzerland",
                    "contacts": [
                        {
                            "name": "Anna Motterle",
                            "role": "CONTACT",
                            "email": "Anna.Motterle@chuv.ch"
                        },
                        {
                            "name": "Antonia Digklia, Dr",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 46.516,
                        "lon": 6.63282
                    }
                },
                {
                    "facility": "University Hospital of Bern (Inselspital)",
                    "status": "RECRUITING",
                    "city": "Bern",
                    "zip": "3010",
                    "country": "Switzerland",
                    "contacts": [
                        {
                            "name": "Lena Albihn-Boland",
                            "role": "CONTACT",
                            "email": "lena.albihn-boland@insel.ch"
                        },
                        {
                            "name": "Martin Berger, Dr",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 46.94809,
                        "lon": 7.44744
                    }
                },
                {
                    "facility": "University Hospitals of Geneva (HUG)",
                    "status": "RECRUITING",
                    "city": "Geneva",
                    "zip": "1205",
                    "country": "Switzerland",
                    "contacts": [
                        {
                            "name": "Virginie Ancrenaz",
                            "role": "CONTACT",
                            "email": "virginie.ancrenaz@hug.ch"
                        },
                        {
                            "name": "Thibaud Koessler",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 46.20222,
                        "lon": 6.14569
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "asFound": "Adenocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}